InsiderTrades.com logo

BCRX Insider Trading

Insider Ownership Percentage: 5.10%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $3,299,164.61

BioCryst Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at BioCryst Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

BioCryst Pharmaceuticals Share Price & Price History

Current Price: $9.70
Price Change: ▼ Price Decrease of -0.11 (-1.12%)
As of 03/20/2026 05:00 PM ET

This chart shows the closing price history over time for BCRX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

BioCryst Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/16/2026Alane P. BarnesInsiderSell150,000$9.15$1,372,500.00400,703View SEC Filing Icon  
12/22/2025Alane P. BarnesInsiderSell21,773$7.65$166,563.45398,751View SEC Filing Icon  
12/3/2025Alane P. BarnesInsiderSell19,770$7.65$151,240.50345,476View SEC Filing Icon  
12/2/2025Alane P. BarnesInsiderSell50,906$7.21$367,032.26365,246View SEC Filing Icon  
12/1/2025Alane P. BarnesInsiderSell91,004$7.10$646,128.40416,152View SEC Filing Icon  
8/13/2025Theresa HeggieDirectorSell70,000$8.51$595,700.0065,352View SEC Filing Icon  
6/24/2024Amy E. McKeeDirectorSell8,600$6.32$54,352.0027,831View SEC Filing Icon  
6/17/2024Machelle SandersDirectorSell4,689$6.00$28,134.0027,742View SEC Filing Icon  
5/30/2024Alan G LevinDirectorBuy7,861$6.36$49,995.9644,951View SEC Filing Icon  
5/24/2024Steve AselageDirectorBuy2,500$6.40$16,000.002,500View SEC Filing Icon  
5/20/2024Nancy J. HutsonDirectorBuy5,000$6.38$31,900.0086,818View SEC Filing Icon  
5/14/2024Anthony DoyleCFOBuy36,300$5.57$202,191.00266,744View SEC Filing Icon  
5/14/2024Helen M. ThackrayInsiderBuy30,000$5.86$175,800.00272,139View SEC Filing Icon  
5/13/2024Steven K. GalsonDirectorBuy21,940$5.49$120,450.6051,551View SEC Filing Icon  
6/15/2023Machelle SandersDirectorSell4,000$7.98$31,920.0025,611View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for BioCryst Pharmaceuticals (NASDAQ:BCRX)

85.88% of BioCryst Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at BCRX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

BioCryst Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
3/20/2026Hsbc Holdings PLC24,133$0.19M0.0%-61.0%0.010%Search for SEC Filing on Google Icon
3/17/2026Rockefeller Capital Management L.P.26,797$0.21M0.0%+403.2%0.011%Search for SEC Filing on Google Icon
2/19/2026Invesco Ltd.1,354,897$10.57M0.0%+40.8%0.643%Search for SEC Filing on Google Icon
2/18/2026Mackenzie Financial Corp150,728$1.15M0.0%+16.6%0.072%Search for SEC Filing on Google Icon
2/18/2026NewEdge Advisors LLC50,041$0.39M0.0%N/A0.024%Search for SEC Filing on Google Icon
2/18/2026XTX Topco Ltd17,111$0.13M0.0%N/A0.008%Search for SEC Filing on Google Icon
2/18/2026Voloridge Investment Management LLC449,743$3.51M0.0%-53.0%0.213%Search for SEC Filing on Google Icon
2/18/2026Vestal Point Capital LP2,250,000$17.55M0.6%N/A1.068%Search for SEC Filing on Google Icon
2/18/2026Virtus Investment Advisers LLC90,278$0.70M0.2%+111.3%0.043%Search for SEC Filing on Google Icon
2/18/2026Wellington Management Group LLP86,520$0.68M0.0%-7.5%0.041%Search for SEC Filing on Google Icon
2/18/2026Susquehanna Portfolio Strategies LLC778,521$6.07M0.1%N/A0.369%Search for SEC Filing on Google Icon
2/18/2026Tudor Investment Corp ET AL114,541$0.89M0.0%+16.7%0.054%Search for SEC Filing on Google Icon
2/18/2026Twinbeech Capital LP23,700$0.19M0.0%-87.9%0.011%Search for SEC Filing on Google Icon
2/18/2026Sphera Funds Management LTD.837,889$6.54M1.2%N/A0.398%Search for SEC Filing on Google Icon
2/18/2026Quantessence Capital LLC13,200$0.10M1.2%N/A0.006%Search for SEC Filing on Google Icon
2/18/2026Orbimed Advisors LLC1,741,800$13.59M0.3%+93.2%0.827%Search for SEC Filing on Google Icon
2/18/2026Perceptive Advisors LLC3,162,529$24.67M0.4%N/A1.501%Search for SEC Filing on Google Icon
2/18/2026Millennium Management LLC137,626$1.07M0.0%-70.1%0.065%Search for SEC Filing on Google Icon
2/18/2026Man Group plc407,850$3.18M0.0%+15.1%0.194%Search for SEC Filing on Google Icon
2/18/2026Ishara Investments LP300,000$2.34M2.7%N/A0.142%Search for SEC Filing on Google Icon
2/18/2026Janus Henderson Group PLC7,404,386$57.79M0.0%+7,807.2%3.514%Search for SEC Filing on Google Icon
2/18/2026Gotham Asset Management LLC216,946$1.69M0.0%-36.9%0.103%Search for SEC Filing on Google Icon
2/18/2026Elmind Capital LP2,150,000$16.77M4.9%N/A1.020%Search for SEC Filing on Google Icon
2/18/2026Engineers Gate Manager LP224,543$1.75M0.0%-49.3%0.107%Search for SEC Filing on Google Icon
2/18/2026Eversept Partners LP2,992,895$23.35M1.2%+117.9%1.420%Search for SEC Filing on Google Icon
2/18/2026Baker BROS. Advisors LP2,822,727$22.02M0.1%N/A1.339%Search for SEC Filing on Google Icon
2/18/2026Banco Bilbao Vizcaya Argentaria S.A.19,249$0.15M0.0%N/A0.009%Search for SEC Filing on Google Icon
2/17/2026ADAR1 Capital Management LLC45,000$0.35M0.0%N/A0.021%Search for SEC Filing on Google Icon
2/17/2026Schonfeld Strategic Advisors LLC141,449$1.10M0.0%-15.2%0.067%Search for SEC Filing on Google Icon
2/17/2026AQR Capital Management LLC704,291$5.49M0.0%-29.6%0.334%Search for SEC Filing on Google Icon
2/17/2026Cetera Investment Advisers12,330$96K0.0%+13.8%0.006%Search for SEC Filing on Google Icon
2/17/2026Abel Hall LLC24,898$0.19M0.0%N/A0.012%Search for SEC Filing on Google Icon
2/17/2026Lazard Asset Management LLC69,598$0.54M0.0%+30.6%0.033%Search for SEC Filing on Google Icon
2/17/2026Jain Global LLC74,455$0.58M0.0%N/A0.035%Search for SEC Filing on Google Icon
2/17/2026RA Capital Management L.P.15,827,186$123.45M1.3%N/A7.510%Search for SEC Filing on Google Icon
2/17/2026Jump Financial LLC910,930$7.11M0.1%-1.5%0.432%Search for SEC Filing on Google Icon
2/17/2026Price T Rowe Associates Inc. MD177,392$1.38M0.0%+9.9%0.084%Search for SEC Filing on Google Icon
2/17/2026Vinva Investment Management Ltd18,733$0.15M0.0%-64.7%0.009%Search for SEC Filing on Google Icon
2/17/2026Osaic Holdings Inc.82,766$0.65M0.0%+34.0%0.039%Search for SEC Filing on Google Icon
2/17/2026Integral Health Asset Management LLC200,000$1.56M0.1%N/A0.095%Search for SEC Filing on Google Icon
2/17/2026California State Teachers Retirement System191,847$1.50M0.0%+5.1%0.091%Search for SEC Filing on Google Icon
2/17/2026Diadema Partners LP190,928$1.49M0.3%N/A0.091%Search for SEC Filing on Google Icon
2/17/2026Russell Investments Group Ltd.229,226$1.79M0.0%-27.1%0.109%Search for SEC Filing on Google Icon
2/17/2026State of Wisconsin Investment Board347,190$2.71M0.0%-7.6%0.165%Search for SEC Filing on Google Icon
2/17/2026Captrust Financial Advisors17,740$0.14M0.0%-9.4%0.008%Search for SEC Filing on Google Icon
2/17/2026Royal Bank of Canada161,456$1.26M0.0%-12.9%0.077%Search for SEC Filing on Google Icon
2/17/2026Graham Capital Management L.P.83,876$0.65M0.0%-68.7%0.040%Search for SEC Filing on Google Icon
2/17/2026Persistent Asset Partners Ltd51,701$0.40M0.2%N/A0.025%Search for SEC Filing on Google Icon
2/17/2026Rice Hall James & Associates LLC1,904,146$14.85M0.8%+1.3%0.904%Search for SEC Filing on Google Icon
2/17/2026University of Texas Texas AM Investment Management Co.64,507$0.50M0.1%N/A0.031%Search for SEC Filing on Google Icon
2/16/2026Squarepoint Ops LLC1,659,192$12.94M0.0%+49.7%0.787%Search for SEC Filing on Google Icon
2/16/2026Panagora Asset Management Inc.88,876$0.69M0.0%-28.2%0.042%Search for SEC Filing on Google Icon
2/16/2026Mariner LLC31,495$0.25M0.0%+60.0%0.015%Search for SEC Filing on Google Icon
2/16/2026Entropy Technologies LP56,517$0.44M0.0%-16.3%0.027%Search for SEC Filing on Google Icon
2/16/2026Barclays PLC726,367$5.67M0.0%-7.1%0.345%Search for SEC Filing on Google Icon
2/16/2026Aigen Investment Management LP28,058$0.22M0.1%-72.1%0.013%Search for SEC Filing on Google Icon
2/13/2026Arete Wealth Advisors LLC16,450$0.13M0.0%-15.4%0.008%Search for SEC Filing on Google Icon
2/13/2026Nantahala Capital Management LLC1,356,377$10.58M0.3%N/A0.644%Search for SEC Filing on Google Icon
2/13/2026The Manufacturers Life Insurance Company 97,634$0.76M0.0%-8.1%0.046%Search for SEC Filing on Google Icon
2/13/2026CANADA LIFE ASSURANCE Co17,374$0.14M0.0%-71.5%0.008%Search for SEC Filing on Google Icon
2/13/2026Bridgewater Associates LP235,572$1.84M0.0%-42.8%0.112%Search for SEC Filing on Google Icon
2/13/2026Stifel Financial Corp1,824,517$14.23M0.0%+0.1%0.866%Search for SEC Filing on Google Icon
2/13/2026Hudson Bay Capital Management LP1,017,374$7.94M0.0%N/A0.483%Search for SEC Filing on Google Icon
2/13/2026Quarry LP30,000$0.23M0.0%N/A0.014%Search for SEC Filing on Google Icon
2/13/2026Commerce Bank39,065$0.31M0.0%+31.5%0.019%Search for SEC Filing on Google Icon
2/13/2026Jacobs Levy Equity Management Inc.1,031,488$8.05M0.0%+178.4%0.489%Search for SEC Filing on Google Icon
2/13/2026Rafferty Asset Management LLC382,556$2.98M0.0%+3.6%0.182%Search for SEC Filing on Google Icon
2/13/2026First Trust Advisors LP374,961$2.93M0.0%-49.0%0.178%Search for SEC Filing on Google Icon
2/13/2026Headlands Technologies LLC118,473$0.92M0.1%+3.6%0.056%Search for SEC Filing on Google Icon
2/13/2026Charles Schwab Investment Management Inc.2,004,939$15.64M0.0%+0.5%0.951%Search for SEC Filing on Google Icon
2/13/2026QTR Family Wealth LLC154,062$1.20M0.5%-2.0%0.073%Search for SEC Filing on Google Icon
2/13/2026State Street Corp11,073,211$86.37M0.0%+12.9%5.254%Search for SEC Filing on Google Icon
2/13/2026UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC378,853$2.96M0.0%-4.0%0.180%Search for SEC Filing on Google Icon
2/13/2026Wells Fargo & Company MN233,639$1.82M0.0%+75.6%0.111%Search for SEC Filing on Google Icon
2/12/2026Empire Financial Management Company LLC100,000$0.78M0.2%N/A0.047%Search for SEC Filing on Google Icon
2/12/2026HRT Financial LP716,826$5.59M0.0%+1,137.9%0.340%Search for SEC Filing on Google Icon
2/12/2026DRW Securities LLC12,397$97K0.0%-88.2%0.006%Search for SEC Filing on Google Icon
2/12/2026Brooklyn Investment Group18,708$0.14M0.0%N/A0.009%Search for SEC Filing on Google Icon
2/12/2026Cibc World Markets Corp13,858$0.11M0.0%N/A0.007%Search for SEC Filing on Google Icon
2/12/2026Commonwealth Equity Services LLC79,747$0.62M0.0%-36.7%0.038%Search for SEC Filing on Google Icon
2/12/2026Renaissance Technologies LLC2,128,821$16.61M0.0%-0.5%1.010%Search for SEC Filing on Google Icon
2/12/2026Dimensional Fund Advisors LP1,228,852$9.59M0.0%N/A0.583%Search for SEC Filing on Google Icon
2/12/2026EntryPoint Capital LLC12,691$99K0.0%-70.0%0.006%Search for SEC Filing on Google Icon
2/12/2026Federated Hermes Inc.292,850$2.28M0.0%+10.3%0.139%Search for SEC Filing on Google Icon
2/12/2026Ensign Peak Advisors Inc14,400$0.11M0.0%-69.2%0.007%Search for SEC Filing on Google Icon
2/12/2026New York State Common Retirement Fund100,690$0.79M0.0%+51.9%0.048%Search for SEC Filing on Google Icon
2/12/2026Campbell & CO Investment Adviser LLC68,559$0.54M0.0%-37.4%0.033%Search for SEC Filing on Google Icon
2/12/2026Elo Mutual Pension Insurance Co123,539$0.96M0.0%-3.1%0.059%Search for SEC Filing on Google Icon
2/12/2026Swiss National Bank394,368$3.08M0.0%+2.3%0.187%Search for SEC Filing on Google Icon
2/12/2026Nuveen LLC3,612,366$28.18M0.0%-0.2%1.714%Search for SEC Filing on Google Icon
2/11/2026Inceptionr LLC13,631$0.11M0.0%+20.5%0.006%Search for SEC Filing on Google Icon
2/11/2026Janney Montgomery Scott LLC26,133$0.20M0.0%-6.3%0.012%Search for SEC Filing on Google Icon
2/11/2026Deutsche Bank AG491,086$3.83M0.0%-54.1%0.233%Search for SEC Filing on Google Icon
2/11/2026GW&K Investment Management LLC3,160,924$24.66M0.2%+43.8%1.500%Search for SEC Filing on Google Icon
2/11/2026LPL Financial LLC24,480$0.19M0.0%+43.9%0.012%Search for SEC Filing on Google Icon
2/11/2026Franklin Resources Inc.570,189$4.45M0.0%+22.5%0.271%Search for SEC Filing on Google Icon
2/11/2026JPMorgan Chase & Co.843,370$6.58M0.0%-25.5%0.400%Search for SEC Filing on Google Icon
2/11/2026Los Angeles Capital Management LLC355,055$2.57M0.0%+14.9%0.168%Search for SEC Filing on Google Icon
2/11/2026WINTON GROUP Ltd15,600$0.12M0.0%N/A0.007%Search for SEC Filing on Google Icon
2/11/2026State of Wyoming51,893$0.41M0.0%+39.9%0.025%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
BioCryst Pharmaceuticals logo
BioCryst Pharmaceuticals, Inc., a biotechnology company, develops oral small-molecule and protein therapeutics to treat rare diseases. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema. It is also developing BCX10013, an oral factor D inhibitor for complement-mediated diseases. The company has collaborations and in-license relationships with the Torii Pharmaceutical Co., Ltd.; Seqirus UK Limited; Shionogi & Co., Ltd.; Green Cross Corporation; National Institute of Allergy and Infectious Diseases; Biomedical Advanced Research and Development Authority; the U.S. Department of Health and Human Services; and The University of Alabama at Birmingham, as well as Albert Einstein College of Medicine of Yeshiva University and Industrial Research, Ltd. BioCryst Pharmaceuticals, Inc. was founded in 1986 and is headquartered in Durham, North Carolina.
Read More on BioCryst Pharmaceuticals

Today's Range

Now: $9.70
Low: $9.64
High: $10.32

50 Day Range

MA: $7.50
Low: $6.24
High: $9.81

52 Week Range

Now: $9.70
Low: $6.00
High: $11.31

Volume

13,128,973 shs

Average Volume

6,140,587 shs

Market Capitalization

$2.43 billion

P/E Ratio

8.08

Dividend Yield

N/A

Beta

0.74

Who are the company insiders with the largest holdings of BioCryst Pharmaceuticals?

BioCryst Pharmaceuticals' top insider shareholders include:
  1. Alane P Barnes (Insider)
  2. Helen M Thackray (Insider)
  3. Anthony Doyle (CFO)
  4. Nancy J Hutson (Director)
  5. Theresa Heggie (Director)
  6. Steven K Galson (Director)
  7. Alan G Levin (Director)
  8. Amy E Mckee (Director)
  9. Machelle Sanders (Director)
  10. Steve Aselage (Director)
Learn More about top insider investors at BioCryst Pharmaceuticals.

Who are the major institutional investors of BioCryst Pharmaceuticals?

BioCryst Pharmaceuticals' top institutional shareholders include:
  1. Vanguard Group Inc. — 10.57%
  2. RA Capital Management L.P. — 7.51%
  3. State Street Corp — 5.25%
  4. Janus Henderson Group PLC — 3.51%
  5. Nuveen LLC — 1.71%
  6. Goldman Sachs Group Inc. — 1.52%
Learn More about top institutional investors of BioCryst Pharmaceuticals stock.

Which major investors are selling BioCryst Pharmaceuticals stock?

During the last quarter, BCRX stock was sold by these institutional investors:
  1. Assenagon Asset Management S.A.
  2. Jupiter Asset Management Ltd.
  3. Deutsche Bank AG
  4. Voloridge Investment Management LLC
  5. Pictet Asset Management Holding SA
  6. First Trust Advisors LP
  7. Millennium Management LLC
  8. AQR Capital Management LLC
Within the previous year, company insiders that have sold BioCryst Pharmaceuticals company stock include:
  1. Alane P Barnes (Insider)
  2. Helen M Thackray (Insider)
Learn More investors selling BioCryst Pharmaceuticals stock.

Which major investors are buying BioCryst Pharmaceuticals stock?

Within the previous quarter, BCRX stock was bought by institutional investors including:
  1. RA Capital Management L.P.
  2. Janus Henderson Group PLC
  3. Perceptive Advisors LLC
  4. Baker BROS. Advisors LP
  5. Vestal Point Capital LP
  6. Elmind Capital LP
  7. Eversept Partners LP
  8. Nantahala Capital Management LLC
In the previous year, these company insiders have bought BioCryst Pharmaceuticals stock:
  1. Alane P Barnes (Insider)
  2. Helen M Thackray (Insider)
  3. Anthony Doyle (CFO)
  4. Nancy J Hutson (Director)
  5. Theresa Heggie (Director)
  6. Steven K Galson (Director)
Learn More investors buying BioCryst Pharmaceuticals stock.